Products
Online Inquiry
13,14-dihydro-15-keto-tetranor PGE2
Cat. No.:
OB0626WX-2783
Appearance:
Liquid
Purity:
≥95%
Identity:
Confirmed by TLC.
Size:
Add to basket
Product Overview
Description:
13,14-dihydro-15-keto-tetranor PGE2 is a primary downstream metabolic product of prostaglandin E2 catabolism. It is generated through a systematic endogenous cascade involving the initial enzymatic reduction of the C-13/C-14 double bond and subsequent C-15 hydroxyl oxidation, followed by alpha-terminus chain shortening and omega-oxidation.
Synonyms:
[1R-(1α,2β,3α)]-3-hydroxy-5-oxo-2-(3-oxooctyl)-cyclopentanepropanoic acid; 13,14-dihydro-15-keto-tetranor Prostaglandin E2; 20675-85-8; 3-((1R,2R,3R)-3-Hydroxy-5-oxo-2-(3-oxooctyl)cyclopentyl)propanoic acid; 9,15-Dioxo-11alpha-hydroxy-2,3,4,5-tetranor-prostanoic acid; 11R-hydroxy-9,15-dioxo-2,3,4,5-tetranor-prostanoic acid
CAS No.:
20675-85-8
Compound CID:
71684706
Formula:
C16H26O5
Formula Weight:
298.4
Specification
Solubility in DMSO:
50 mg/mL
Solubility in Ethanol:
50 mg/mL
Solubility in DMF:
50 mg/mL
Solubility in Other Solvents:
PBS: 1 mg/mL
Storage:
Storage at -20°C.
Applications:
13,14-dihydro-15-keto-tetranor PGE2 supports research on prostaglandin E2 metabolism and tetranor prostanoid metabolite analysis. It is utilized in lipid mediator profiling, quantitative analytical workflows, and characterization of prostaglandin degradation products.
